EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Epstein–Barr virus capture sequencing identifies BBLF4-L322M as an independent prognostic variant in nasopharyngeal carcinoma

Shi Luo, Zongjian Huang, Nan Shi, Fangfang Chen, Weiren Xiang, Yu Ren, Wei Xia iD, Anzhou Tang iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02927-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Shi Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, HSTD | Natural Science Foundation of Hunan Province (), Guangxi Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV) is etiologically linked to nasopharyngeal carcinoma (NPC) and shows geographic heterogeneity. To determine whether viral genotype affects prognosis, we performed capture-based whole-genome sequencing of EBV from 114 Guangxi NPC biopsies (mean breadth ~93%, depth ~979×) with Sanger confirmation at BNRF1-G696R. We detected 5,683 high-confidence variants with a mean of 1,112 per genome enriched in latent genes (LMP1, LMP2A/B, and the EBNA family). Variants with minor allele frequency ≥0.15 and missingness ≤0.05 were tested for association with 5-year overall survival. A total of 46 loci were significant in the univariate Cox models, and 19 missense variants underwent unsupervised clustering by genotype correlation, yielding two blocks. From these, BZLF1-A205S and BBLF4-L322M were selected as the index variants. In multivariable Cox models adjusted for age and dichotomized American Joint Committee on Cancer (AJCC) stage, BBLF4-L322M remained independently associated with poorer overall survival (OS), whereas BZLF1-A205S was not significant. A 720-genome phylogeny integrating our sequences with public data showed several Chinese sublineages with partial regional structuring. Guangxi strains were closely related to, yet partly distinct from, Guangdong and Hong Kong. These results support the incorporation of the EBV genotype, particularly BBLF4-L322M, into prognostic models and motivate functional studies to define mechanisms and validate their clinical utility. IMPORTANCE The prognostic Epstein–Barr virus (EBV) variants in nasopharyngeal carcinoma (NPC) remain largely unknown. This study presents the first genome-wide survey of EBV sequence diversity in patients with NPC in Guangxi, China. The identified mutations, including BZLF1-A205S and BBLF4-L322M, are candidate viral biomarkers linked to patient survival. The abundance of nonsynonymous variants in latent phase genes implies a role for the viral genotype in the disease course. These insights have laid the groundwork for EBV-based prognostic biomarkers and precise medical strategies tailored to endemic NPC populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanNasopharyngeal CarcinomaEpstein-Barr Virus InfectionsNasopharyngeal NeoplasmsViral ProteinsHumansPrognosisFemaleMaleGenotypeMiddle AgedTrans-ActivatorsWhole Genome SequencingChinaGenome, ViralAdultAged

Stichwörter der Autor:innen

BBLF4-L322MEpstein–Barr virus (EBV)capture-based whole-genome sequencingnasopharyngeal carcinoma (NPC)viral prognostic biomarkers

Substanzen

Trans-ActivatorsViral Proteins

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumours (Guangxi Medical University), Ministry of Education, Nanning, Guangxi, China.
  • Department of Otorhinolaryngology and Head and Neck Surgery, The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou, China.

ORCID-Profile: Wei Xia, Anzhou Tang

Förderung

  • National Natural Science Foundation of China
  • HSTD | Natural Science Foundation of Hunan Province ()
  • Guangxi Science and Technology Program

Zitieren

APA

Luo, S., Huang, Z., Shi, N., Chen, F., Xiang, W., Ren, Y., Xia, W., & Tang, A. (2026). Targeted Epstein–Barr virus capture sequencing identifies BBLF4-L322M as an independent prognostic variant in nasopharyngeal carcinoma. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02927-25

Vancouver

Luo S, Huang Z, Shi N, Chen F, Xiang W, Ren Y, et al. Targeted Epstein–Barr virus capture sequencing identifies BBLF4-L322M as an independent prognostic variant in nasopharyngeal carcinoma. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02927-25

BibTeX
@article{Luo2026,
  author = {Luo, Shi and Huang, Zongjian and Shi, Nan and Chen, Fangfang and Xiang, Weiren and Ren, Yu and Xia, Wei and Tang, Anzhou},
  title = {Targeted Epstein–Barr virus capture sequencing identifies BBLF4-L322M as an independent prognostic variant in nasopharyngeal carcinoma},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02927-25}
}
Kostenlos starten →